TY - JOUR AR - RDI-2020-4-102 TI - Cardiac Magnetic Resonance Imaging in Patients with COVID-19 AU - Ali Kemal, Erenler AU - Seval , Komut AU - Ahmet , Baydin JO - Radiology and Medical Diagnostic Imaging PY - 2020 DA - Mon 09, Nov 2020 SN - 2613-7836 DO - http://dx.doi.org/10.31487/j.RDI.2020.04.02 UR - https://www.sciencerepository.org/cardiac-magnetic-resonance-imaging-in-patients-with-covid-19_RDI-2020-4-102 KW - COVID-19, cardiac magnetic resonance imaging, myocarditis, diagnosis AB - In the beginning of December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was determined in Wuhan, Hubei, China. Besides its predominant respiratory system-related symptoms, cardiovascular involvement has also been described in adults with direct and indirect cardiac injury. Pre-existing cardiovascular disease and cardiac risk factors have been shown to increase the risk of cardiac complications of COVID-19 infection. However, it is also known that healthy and asymptomatic COVID-19 survivors suffer cardiac damage-related complications. Cardiac Magnetic Resonance Imaging (CMRI) is known to be the reference non-invasive standard to present cardiac function and tissue characterization. It is recommended as an effective and efficient diagnostic imaging choice to obtain critical information for clinical diagnosis and decision-making. In this article, we sought the usefulness of CMRI in cardiovascular complications related to COVID-19.